Major indices finish lower amid GE earnings disappointment >>> READ MORE


Recent Articles

Why Rite Aid Corporation (RAD) Stock Can Survive These Stormy Waters

After the Walgreens deal, Rite Aid (RAD) is left with about 2,400 pharmacies, manageable debt and a growing pharmacy benefit manager, all of which can help RAD stock live on. More 

Rite Aid Corporation (RAD) Stock Will Never Be the Same Again

Rite Aid (RAD) stock is getting new life as investors shift their focus on the beaten up name, making RAD stock worthy enough to buy. More 

Rite Aid Corporation (RAD) Stock Is a No-Brainer Buy. Seriously.

From a risk-versus-reward perspective, Rite Aid is a no-brainer. Expect RAD stock to trade between $4 and $6 per share a year from now. More 

Rite Aid Corporation (RAD) Stock Is On Life Support

Rite Aid Corporation could be quite a steal for a daring private equity firm, but will one step in to save flat-lining RAD stock? More 

3 Reasons Rite Aid Corporation (RAD) Stock Still Has a Chance

RAD stock has fallen significantly on bad news; however, Rite Aid isn’t in as bad a position as the market made it out to be. More 

Avoid Rite Aid Corporation (RAD) and Walgreens Boots Alliance Inc (RAD)

Forget about merger winners and losers here. Avoid Walgreens (WBA), Rite Aid (RAD) stock and the rest of the drugstore space. More 

Don’t Chase Rite Aid Corporation (RAD) Stock Down the Toilet

Rite Aid has plunged because its merger with Walgreens has morphed into something else. But that's not the only reason RAD stock is toxic. More